{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:45Z","timestamp":1791928785344,"version":"4.3.4"},"reference-count":35,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,11,30]]},"DOI":"10.1167\/iovs.62.14.30","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:32:34Z","timestamp":1638271954000},"page":"30","source":"Crossref","is-referenced-by-count":19,"title":["Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies"],"prefix":"10.1167","volume":"62","author":[{"given":"Leonard A.","family":"Levin","sequence":"first","affiliation":[{"name":"Departments of Ophthalmology and Visual Sciences, Neurology & Neurosurgery, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohor","family":"Sengupta","sequence":"additional","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Balcer","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Ophthalmology, and Population Health, New York University Grossman School of Medicine, New York, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Kupersmith","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Ophthalmology, and Neurosurgery, Icahn School of Medicine at Mount Sinai and New York Eye and Ear Infirmary, New York, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Miller","sequence":"additional","affiliation":[{"name":"Neuro-Ophthalmology Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","article-title":"A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol","volume":"135","author":"Beck","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"bib2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bjophthalmol-2019-315124","article-title":"Validation of electronic visual acuity (EVA) measurement against standardised ETDRS charts in patients with visual field loss from inherited retinal degenerations","volume":"104","author":"Jolly","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"bib4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1167\/iovs.10-6075","article-title":"Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry","volume":"52","author":"Meleth","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.12.002","article-title":"Evaluating the usefulness of MP-3 microperimetry in glaucoma patients","volume":"187","author":"Matsuura","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"bib6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1167\/iovs.16-20309","article-title":"The pattern of retinal ganglion cell loss in OPA1-related autosomal dominant optic atrophy inferred from temporal, spatial, and chromatic sensitivity losses","volume":"58","author":"Majander","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"bib7","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1167\/iovs.14-14860","article-title":"CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function","volume":"55","author":"Zein","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1167\/iovs.10-6283","article-title":"Rapid quantification of color vision: the cone contrast test","volume":"52","author":"Rabin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s00415-019-09246-8","article-title":"Color perception impairment following optic neuritis and its association with retinal atrophy","volume":"266","author":"Levin","year":"2019","journal-title":"J Neurol"},{"issue":"4","key":"bib10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11136-018-2030-1","article-title":"The impacts of abnormal color vision on people's life: an integrative review","volume":"28","author":"Stoianov","year":"2019","journal-title":"Qual Life Res"},{"issue":"5","key":"bib11","first-page":"1017","article-title":"The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial","volume":"41","author":"Cole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"bib12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis","volume":"68","author":"Balcer","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"bib13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","article-title":"Ganglion cell loss in relation to visual disability in multiple sclerosis","volume":"119","author":"Walter","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"issue":"21","key":"bib15","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"bib16","article-title":"Development and content of a database of systematic reviews for eyes and vision [published online April 6, 2021]","author":"L\u00ea","journal-title":"Eye (Lond)"},{"issue":"10","key":"bib17","doi-asserted-by":"publisher","first-page":"e109400","DOI":"10.1371\/journal.pone.0109400","article-title":"Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability","volume":"9","author":"Saldanha","year":"2014","journal-title":"PLoS One"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jclinepi.2017.05.007","article-title":"Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis","volume":"86","author":"Mayo-Wilson","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"bib19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/jamaophthalmol.2016.2101","article-title":"Assessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devices","volume":"134","author":"Le","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"bib20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/bjophthalmol-2016-309695","article-title":"Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma","volume":"101","author":"Law","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"bib21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/jamaophthalmol.2017.2583","article-title":"Comparison of clinical trial and systematic review outcomes for the 4 most prevalent eye diseases","volume":"135","author":"Saldanha","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"bib22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaophthalmol.2018.3352","article-title":"Research questions and outcomes prioritized by patients with dry eye","volume":"136","author":"Saldanha","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"bib23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ophtha.2018.09.008","article-title":"Choosing core outcomes for use in clinical trials in ophthalmology: perspectives from three ophthalmology outcomes working groups","volume":"126","author":"Saldanha","year":"2019","journal-title":"Ophthalmology"},{"issue":"12","key":"bib24","doi-asserted-by":"publisher","first-page":"e2030824","DOI":"10.1001\/jamanetworkopen.2020.30824","article-title":"Association of optical coherence tomography with longitudinal neurodegeneration in veterans with chronic mild traumatic brain injury","volume":"3","author":"Gilmore","year":"2020","journal-title":"JAMA Netw Open"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.preteyeres.2016.12.002","article-title":"Improving our understanding, and detection, of glaucomatous damage: an approach based upon optical coherence tomography (OCT)","volume":"57","author":"Hood","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1073\/pnas.1613445114","article-title":"Imaging individual neurons in the retinal ganglion cell layer of the living eye","volume":"114","author":"Rossi","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"48","key":"bib27","doi-asserted-by":"publisher","first-page":"12803","DOI":"10.1073\/pnas.1711734114","article-title":"Imaging and quantifying ganglion cells and other transparent neurons in the living human retina","volume":"114","author":"Liu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"bib28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.62.3.34","article-title":"Quantification of retinal ganglion cell morphology in human glaucomatous eyes","volume":"62","author":"Liu","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib29","doi-asserted-by":"publisher","first-page":"e0207102","DOI":"10.1371\/journal.pone.0207102","article-title":"Functional architecture of the foveola revealed in the living primate","volume":"13","author":"McGregor","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"bib30","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41467-020-15317-6","article-title":"Optogenetic restoration of retinal ganglion cell activity in the living primate","volume":"11","author":"McGregor","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"bib31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1167\/iovs.15-17946","article-title":"In vivo two-photon fluorescence kinetics of primate rods and cones","volume":"57","author":"Sharma","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"23","key":"bib32","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1364\/OL.44.005671","article-title":"Simultaneous functional imaging of neuronal and photoreceptor layers in living human retina","volume":"44","author":"Pfaffle","year":"2019","journal-title":"Opt Lett"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.msard.2020.102400","article-title":"Promising recovery biomarkers after first event acute demyelinating optic neuritis","volume":"45","author":"Klineova","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"bib34","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","article-title":"Simplified modified Rankin scale questionnaire: reproducibility over the telephone and validation with quality of life","volume":"42","author":"Bruno","year":"2011","journal-title":"Stroke"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trial.","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:27Z","timestamp":1791927087000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.14.30","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}